T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $8.94M | ﹤0.01% |
110,178
-4,041,457
| -97% | -$323M |
|
|
THRD
1077
DELISTED
Third Harmonic Bio
THRD
| $8.93M | ﹤0.01% |
+470,626
| New | +$8.48M |
|
1078
Cloudflare
NET
$118B
| $8.89M | ﹤0.01% |
160,767
+14,151
| +10% | +$840K |
|
1079
Lumen
LUMN
$6.6B
| $8.88M | ﹤0.01% |
1,219,089
-3,542
| -0.3% | -$36K |
|
1080
Belden
BDC
$5.36B
| $8.87M | ﹤0.01% |
147,754
-2,953,616
| -95% | -$188M |
|
1081
Remitly
RELY
$5.39B
| $8.81M | ﹤0.01% |
792,042
+539,702
| +214% | +$5.63M |
|
1082
Carnival Corporation Ltd
CCL
$38.9B
| $8.8M | ﹤0.01% |
1,252,123
+206,785
| +20% | +$2M |
|
1083
Carlisle Companies
CSL
$14.9B
| $8.79M | ﹤0.01% |
31,358
+168
| +0.5% | +$48.2K |
|
1084
iShares Core US Aggregate Bond ETF
AGG
$138B
| $8.77M | ﹤0.01% |
91,004
-365,100
| -80% | -$36.9M |
|
1085
Senti Biosciences Holdings
SNTI
$12M
| $8.71M | ﹤0.01% |
401,548
+42,589
| +12% | +$839K |
|
1086
Patrick Industries
PATK
$2.78B
| $8.69M | ﹤0.01% |
297,413
-80,782
| -21% | -$2.94M |
|
1087
Philips
PHG
$26.8B
| $8.68M | ﹤0.01% |
530,690
-45,371,219
| -99% | -$737M |
|
1088
Universal Health Services
UHS
$10.1B
| $8.57M | ﹤0.01% |
97,213
-17
| -0% | -$1.76K |
|
1089
Woodward
WWD
$21.2B
| $8.56M | ﹤0.01% |
106,617
-194,415
| -65% | -$18.4M |
|
1090
Metropolitan Bank Holding Corp
MCB
$1.17B
| $8.49M | ﹤0.01% |
131,934
-359,687
| -73% | -$25.5M |
|
1091
Pentair
PNR
$10.7B
| $8.42M | ﹤0.01% |
207,154
+7,759
| +4% | +$360K |
|
1092
RH
RH
$3.4B
| $8.2M | ﹤0.01% |
33,299
-176,503
| -84% | -$47.6M |
|
|
AVLR
1093
DELISTED
Avalara, Inc.
AVLR
| $8.19M | ﹤0.01% |
89,208
-366,778
| -80% | -$32.9M |
|
1094
Ollie's Bargain Outlet
OLLI
$4.7B
| $8.18M | ﹤0.01% |
158,453
-3,847,762
| -96% | -$238M |
|
1095
Marqeta
MQ
$1.71B
| $8.13M | ﹤0.01% |
285,499
+4,800
| +2% | +$160K |
|
1096
Genmab
GMAB
$19.3B
| $8.1M | ﹤0.01% |
252,198
| – | – |
|
1097
Carriage Services
CSV
$555M
| $8.1M | ﹤0.01% |
251,752
+14,913
| +6% | +$557K |
|
|
THRX
1098
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $8.01M | ﹤0.01% |
1,381,489
-3,794
| -0.3% | -$26.8K |
|
1099
Wolfspeed
WOLF
$1.64B
| $7.98M | ﹤0.01% |
77,215
-1,209,387
| -94% | -$116M |
|
1100
Encore Capital Group
ECPG
$2.15B
| $7.92M | ﹤0.01% |
174,089
-1,158,442
| -87% | -$66.6M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.